lifestyle.marketresearchjournals.com

Author: IceCure Medical Ltd

IceCure Celebrates American Society of Breast Surgeons’ (ASBrS) Proposed Breast Cancer Treatment Guidelines Which Include Cryoablation for Low-Risk Breast Cancer

January 28, 2026
IceCure CEO Issues Letter to Shareholders: Reports Record Fourth Quarter and Full Year 2025 ProSense® Sales

January 12, 2026
IceCure Expected to Report Record Fourth Quarter Sales in North America Driven by Recent FDA Clearance of ProSense® Cryoablation for Low-Risk Breast Cancer

December 23, 2025